Description
Riesgo de hemorragias graves
PRINCIPIO ACTIVO: LINCOMICINA
IBRANCE® 75 mg es un medicamento antineoplásico cuyo principio activo es Palbociclib
Prevención de eventos cardiovasculares en pacientes con riesgo elevado
DOSIS: 500/400 MG
GELBECK 25 MG CAPS 10 GEDEON RICHTER Riesgo de hemorragias gravesCaja C 10 Cpsulas
Exchange/Return Notes
- We offer a 30-day return/exchange service after receiving.
- Final sale items are not eligible for returns or exchanges.
- To process your return/exchange, please contact us at [email protected]
- Please click here for more details>>> Return & Exchange Policy
You may also like
recommand products
